CD4 and neoplasm: Following the delivery of IL-12 with FUS + microbubbles, flow cytometry analysis reported an upregulation of T lymphocyte population, including CD3+ and CD4+, which correlated with impairment of tumor growth compared to IL-12 administration alone (Chen et al., 2015).